India to United States: Sodium Export Trade Route
India has recorded 8,915 verified shipments of Sodium exported to United States, representing a combined trade value of $1.6B USD. This corridor is served by 125 active Indian exporters, with an average shipment value of $175.0K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 53% of total export value with 210 shipments worth $830.4M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $814.6M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLAND PHARMA LTD — together control 68% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Sodium corridor is one of India's established pharmaceutical export routes, with 8,915 shipments documented worth a combined $1.6B USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's sodium manufacturing sector.
Across 125 active suppliers, the average shipment value stands at $175.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with sodium's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 14.6%, placing it at rank #19 among India's top sodium export destinations globally.
On the import side, key buyers of Indian sodium in United States include MYLAN PHARMACEUTICALS INC,, UNICHEM PHARMACEUTICALS (USA) INC., FRESENIUS KABI USA, LLC and 423 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 45 shipments valued at $814.6M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#19
- Annual growth+14.6%
- Demand growth+12.8%
- Regulatory ease83/100
Top 10 Indian Sodium Exporters to United States
Showing top 10 of 125 Indian suppliers exporting Sodium to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $4.0M per shipment | 210 | $830.4M | 53.2% |
| 2 | UNICHEM LABORATORIES LIMITED Avg $247.6K per shipment | 569 | $140.9M | 9.0% |
| 3 | GLAND PHARMA LTD Avg $102.9K per shipment | 866 | $89.1M | 5.7% |
| 4 | MACLEODS PHARMACEUTICALS LTD Avg $325.0K per shipment | 262 | $85.1M | 5.5% |
| 5 | GLAND PHARMA LIMITED Avg $152.0K per shipment | 266 | $40.4M | 2.6% |
| 6 | DR.REDDY'S LABORATORIES LTD Avg $45.8K per shipment | 826 | $37.8M | 2.4% |
| 7 | EUGIA PHARMA SPECIALITIES LIMITED Avg $100.9K per shipment | 335 | $33.8M | 2.2% |
| 8 | RUBICON RESEARCH PRIVATE LIMITED Avg $387.0K per shipment | 69 | $26.7M | 1.7% |
| 9 | MICRO LABS LIMITED Avg $401.6K per shipment | 66 | $26.5M | 1.7% |
| 10 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $42.3K per shipment | 567 | $24.0M | 1.5% |
This table shows the top 10 of 125 Indian companies exporting sodium to United States, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLAND PHARMA LTD, MACLEODS PHARMACEUTICALS LTD, GLAND PHARMA LIMITED, DR.REDDY'S LABORATORIES LTD, EUGIA PHARMA SPECIALITIES LIMITED, RUBICON RESEARCH PRIVATE LIMITED, MICRO LABS LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 210 shipments worth $830.4M USD, giving it a 53% market share. The top 3 suppliers together account for 68% of the total trade value on this route.
Showing top 10 of 125 total Indian exporters on the India to United States Sodium export route.
Top 10 Sodium Importers in United States
Showing top 10 of 426 known buyers in United States receiving Sodium shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sodium in United States include MYLAN PHARMACEUTICALS INC,, UNICHEM PHARMACEUTICALS (USA) INC., FRESENIUS KABI USA, LLC, EVERSANA, UNICHEM PHARMACEUTICALS(USA)INC, among 426 total buyers. The largest importer is MYLAN PHARMACEUTICALS INC,, accounting for $814.6M USD across 45 shipments — representing 52% of all sodium imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC, | 45 | $814.6M | 52.2% |
| 2 | UNICHEM PHARMACEUTICALS (USA) INC. | 198 | $86.0M | 5.5% |
| 3 | FRESENIUS KABI USA, LLC | 379 | $40.2M | 2.6% |
| 4 | EVERSANA | 361 | $39.2M | 2.5% |
| 5 | UNICHEM PHARMACEUTICALS(USA)INC | 10 | $37.8M | 2.4% |
| 6 | AMERISOURCE HEALTH SERVICES | 100 | $31.0M | 2.0% |
| 7 | MACLEODS PHARMA USA ,INC | 23 | $25.2M | 1.6% |
| 8 | RELIABLE HEALTHCARE LOGISTICS LLC | 9 | $24.6M | 1.6% |
| 9 | EUGIA US LLC | 241 | $24.2M | 1.6% |
| 10 | EVERSANA LIFE SCIENCE SERVICES, LLC | 29 | $22.1M | 1.4% |
Showing top 10 of 426 Sodium importers in United States on this route.
Top 10 Sodium Formulations Imported by United States
Showing top 10 of 4,085 product formulations shipped on the India to United States Sodium route, ranked by trade value
United States imports a wide range of sodium formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 29280 PACKS — accounts for $404.6M USD across 1 shipments. There are 4,085 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 29280 PACKS | 1 | $404.6M | 25.9% |
| 2 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 9837 PACKS | 1 | $135.7M | 8.7% |
| 3 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT9811 PACKS | 1 | $135.3M | 8.7% |
| 4 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 9797 PACKS | 1 | $135.1M | 8.7% |
| 5 | DIVALPROEX SODIUM DR 250MG TABLETS 500T DIVALPROEX SODIUM DELAYED RELEASE TAB USP 250MG NDC CODE: 2930013905 BOTTLE OF 5 | 1 | $29.0M | 1.9% |
| 6 | MONTELUKAST SODIUM 10MG TABLETS-NDC NO.NO.68001-0361-03, BATCH NO.BMC92355A,BMC92357A,BMC92356A,M.DT.10/23,E.DT.9/26, | 1 | $27.7M | 1.8% |
| 7 | DIVALPROEX SODIUM DR 500MG TABLETS 500T DIVALPROEX SODIUM DELAYED RELEASE TAB USP 500MG BNO;ZDPH23190(2280 BT) | 1 | $26.3M | 1.7% |
| 8 | DIVALPROEX SODIUM DELAYED RELEASE TABLETS USP 500MG [2274 BTL X 500' TAB] BATCHNO. ZDPH23192 & ZDPH23193 MFG DT. 12/23 | 1 | $26.3M | 1.7% |
| 9 | MONTELUKAST SODIUM TABLETS 10MG BNO. BMC92352A/BMC92354A MD 10/23,EX.09/26 PS.1X500S | 1 | $23.6M | 1.5% |
| 10 | DIVALPROEX SODIUM DELAYED RELEASE TABLETS USP 125MG [5025 BTL X 500' TAB] BATCHNO. ZDPL23023 & ZDPL23024 MFG DT. 12/23 | 1 | $21.0M | 1.3% |
Showing top 10 of 4,085 Sodium formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 1413 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's sodium exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 210 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 125 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLAND PHARMA LTD — together account for 68% of total trade value on this route. The average shipment value of $175.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pantoprazole sodium delayed-release tablets usp 40 mg 1000bt 9837 packs and pantoprazole sodium delayed-release tablets usp 40 mg 1000bt9811 packs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 45 shipments worth $814.6M USD — representing 52% of all sodium imports from India on this route. A total of 426 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.6B
- Avg. Shipment
- $175.0K
- Suppliers
- 125
- Buyers
- 426
- Transit (Sea)
- ~33 days
- Annual Growth
- +14.6%
Reverse Direction
United States → India — Sodium (Import)Other Sodium Routes
Sodium — Export Intelligence Video
Visual overview of India's sodium India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Sodium Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 8,915 shipments on this route.
Frequently Asked Questions — India to United States Sodium Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sodium to United States?
The leading Indian exporters of Sodium to United States are MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLAND PHARMA LTD. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 53% of total trade value on this route.
Q What is the total value of Sodium exports from India to United States?
India exports Sodium to United States worth approximately $1.6B USD across 8,915 recorded shipments. The average value per shipment is $175.0K USD.
Q Which ports does India use to ship Sodium to United States?
The most active port of origin is HYDERABAD ICD with 1413 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Sodium?
The average transit time for Sodium shipments from India to United States is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Sodium trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.6% with demand growth tracking at 12.8%. The route is ranked #19 among India's top Sodium export destinations globally.
Q How many suppliers are active on the India to United States Sodium route?
There are currently 125 active Indian suppliers exporting Sodium to United States. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 53% of total shipment value.
Q Who are the main importers of Sodium from India in United States?
The leading importers of Indian Sodium in United States include MYLAN PHARMACEUTICALS INC,, UNICHEM PHARMACEUTICALS (USA) INC., FRESENIUS KABI USA, LLC, EVERSANA, UNICHEM PHARMACEUTICALS(USA)INC. MYLAN PHARMACEUTICALS INC, is the largest buyer with 45 shipments worth $814.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Sodium.
- 2.Supplier/Buyer Matching: 125 Indian exporters and 426 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 8,915 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,915 Verified Shipments
125 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists